Humanitas Research Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Humanitas Research Hospital takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions cover upper gastrointestinal tumours, brain tumours and head and neck cancer. It presents a randomised trial adding trotabresib to radiotherapy and temozolomide in newly diagnosed IDH wild-type glioblastoma.
| Organization | ESMO 2026 Attendance |
|---|---|
Humanitas Research Hospital Rozzano, Italy | |
Private research and teaching hospital in Rozzano, near Milan, Italy, recognised as a scientific research hospital by the Italian health ministry. | Chair Sat Oct 24 10:15–11:45 Proffered paper 2: Gastrointestinal tumours, upper digestive Gastrointestinal cancers Abstract Sat Oct 24 11:20–11:32 Invited Discussant LBA48 and 1679O Gastrointestinal cancers Abstract Sun Oct 25 10:53–11:03 Chair Sun Oct 25 14:45–16:15 Rapid oral: Head and neck cancer Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 15:00–15:12 Invited Discussant LBA46, 1536RO and 1537RO Sarcoma, CNS, head & neck and rare cancers |
Instantly find 20 buyers from Humanitas Research Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction